313 related articles for article (PubMed ID: 28064277)
1. Smad2 Phosphorylation in Diabetic Kidney Tubule Epithelial Cells Is Associated with Modulation of Several Transforming Growth Factor-β Family Members.
Høj Thomsen L; Fog-Tonnesen M; Nielsen Fink L; Norlin J; de Vinuesa AG; Krarup Hansen T; de Heer E; Ten Dijke P; Rosendahl A
Nephron; 2017; 135(4):291-306. PubMed ID: 28064277
[TBL] [Abstract][Full Text] [Related]
2. FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy.
Loeffler I; Liebisch M; Allert S; Kunisch E; Kinne RW; Wolf G
Cell Tissue Res; 2018 Apr; 372(1):115-133. PubMed ID: 29209813
[TBL] [Abstract][Full Text] [Related]
3. Disparate phospho-Smad2 levels in advanced type 2 diabetes patients with diabetic nephropathy and early experimental db/db mouse model.
Thomsen LH; Fog-Tonnesen M; Nielsen Fink L; Norlin J; García de Vinuesa A; Hansen TK; de Heer E; Ten Dijke P; Rosendahl A
Ren Fail; 2017 Nov; 39(1):629-642. PubMed ID: 28805484
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast Growth Factor 21 Attenuates Diabetes-Induced Renal Fibrosis by Negatively Regulating TGF-β-p53-Smad2/3-Mediated Epithelial-to-Mesenchymal Transition via Activation of AKT.
Lin S; Yu L; Ni Y; He L; Weng X; Lu X; Zhang C
Diabetes Metab J; 2020 Feb; 44(1):158-172. PubMed ID: 31701691
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
[TBL] [Abstract][Full Text] [Related]
6. Diminution of microRNA-98 alleviates renal fibrosis in diabetic nephropathy by elevating Nedd4L and inactivating TGF-β/Smad2/3 pathway.
Zeng Y; Feng Z; Liao Y; Yang M; Bai Y; He Z
Cell Cycle; 2020 Dec; 19(24):3406-3418. PubMed ID: 33315506
[TBL] [Abstract][Full Text] [Related]
7. Imperatorin ameliorates kidney injury in diabetic mice by regulating the TGF-β/Smad2/3 signaling axis, epithelial-to-mesenchymal transition, and renal inflammation.
Kundu S; Ghosh A; Yadav KS; Mugale MN; Sahu BD
Eur J Pharmacol; 2024 Jan; 963():176250. PubMed ID: 38092315
[TBL] [Abstract][Full Text] [Related]
8. Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria.
Wang A; Ziyadeh FN; Lee EY; Pyagay PE; Sung SH; Sheardown SA; Laping NJ; Chen S
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1657-65. PubMed ID: 17804483
[TBL] [Abstract][Full Text] [Related]
9. A novel role of LRP5 in tubulointerstitial fibrosis through activating TGF-β/Smad signaling.
He X; Cheng R; Huang C; Takahashi Y; Yang Y; Benyajati S; Chen Y; Zhang XA; Ma JX
Signal Transduct Target Ther; 2020 Apr; 5(1):45. PubMed ID: 32345960
[TBL] [Abstract][Full Text] [Related]
10. Enhanced TGF-beta/Smad signaling in the early stage of diabetic nephropathy is independent of the AT1a receptor.
Okazaki Y; Yamasaki Y; Uchida HA; Okamoto K; Satoh M; Maruyama K; Maeshima Y; Sugiyama H; Sugaya T; Kashihara N; Makino H
Clin Exp Nephrol; 2007 Mar; 11(1):77-87. PubMed ID: 17385003
[TBL] [Abstract][Full Text] [Related]
11. Repression of let-7 by transforming growth factor-β1-induced Lin28 upregulates collagen expression in glomerular mesangial cells under diabetic conditions.
Park JT; Kato M; Lanting L; Castro N; Nam BY; Wang M; Kang SW; Natarajan R
Am J Physiol Renal Physiol; 2014 Dec; 307(12):F1390-403. PubMed ID: 25354942
[TBL] [Abstract][Full Text] [Related]
12. The renal expression of transforming growth factor-beta isoforms and their receptors in acute and chronic experimental diabetes in rats.
Hill C; Flyvbjerg A; Grønbaek H; Petrik J; Hill DJ; Thomas CR; Sheppard MC; Logan A
Endocrinology; 2000 Mar; 141(3):1196-208. PubMed ID: 10698197
[TBL] [Abstract][Full Text] [Related]
13. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.
Marchant V; Droguett A; Valderrama G; Burgos ME; Carpio D; Kerr B; Ruiz-Ortega M; Egido J; Mezzano S
Am J Physiol Renal Physiol; 2015 Sep; 309(6):F559-68. PubMed ID: 26155842
[TBL] [Abstract][Full Text] [Related]
14. Astragaloside effect on TGF-β1, SMAD2/3, and α-SMA expression in the kidney tissues of diabetic KKAy mice.
Wang Y; Lin C; Ren Q; Liu Y; Yang X
Int J Clin Exp Pathol; 2015; 8(6):6828-34. PubMed ID: 26261569
[TBL] [Abstract][Full Text] [Related]
15. Betanin, isolated from fruits of Opuntia elatior Mill attenuates renal fibrosis in diabetic rats through regulating oxidative stress and TGF-β pathway.
Sutariya B; Saraf M
J Ethnopharmacol; 2017 Feb; 198():432-443. PubMed ID: 28111218
[TBL] [Abstract][Full Text] [Related]
16. Cellular basis of diabetic nephropathy: II. The transforming growth factor-beta system and diabetic nephropathy lesions in type 1 diabetes.
Huang C; Kim Y; Caramori ML; Fish AJ; Rich SS; Miller ME; Russell GB; Mauer M
Diabetes; 2002 Dec; 51(12):3577-81. PubMed ID: 12453917
[TBL] [Abstract][Full Text] [Related]
17. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy.
Moon JA; Kim HT; Cho IS; Sheen YY; Kim DK
Kidney Int; 2006 Oct; 70(7):1234-43. PubMed ID: 16929250
[TBL] [Abstract][Full Text] [Related]
18. BMP-7 inhibits renal fibrosis in diabetic nephropathy via miR-21 downregulation.
Liu L; Wang Y; Yan R; Liang L; Zhou X; Liu H; Zhang X; Mao Y; Peng W; Xiao Y; Zhang F; Liu L; Shi M; Guo B
Life Sci; 2019 Dec; 238():116957. PubMed ID: 31655195
[TBL] [Abstract][Full Text] [Related]
19. Reduced beta 2 glycoprotein I improves diabetic nephropathy via inhibiting TGF-β1-p38 MAPK pathway.
Wang T; Chen SS; Chen R; Yu DM; Yu P
Int J Clin Exp Pathol; 2015; 8(3):2321-33. PubMed ID: 26045739
[TBL] [Abstract][Full Text] [Related]
20. Role of IGFBP7 in Diabetic Nephropathy: TGF-β1 Induces IGFBP7 via Smad2/4 in Human Renal Proximal Tubular Epithelial Cells.
Watanabe J; Takiyama Y; Honjyo J; Makino Y; Fujita Y; Tateno M; Haneda M
PLoS One; 2016; 11(3):e0150897. PubMed ID: 26974954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
